These variants can act extracellularly on CD99 to induce cell death in EWS cells without affecting DNA synthesis, exhibiting greater specificity for targeting CD99 expressed in cancer cells while demonstrating much lower toxicity towards normal proliferating cells [139]. The gene discussed is CD99; the disease is cancer.